Most searched codes in this range
Monthly US Google searches for the bare code (Google Ads, October 2026) show which entries coders and billers look up most; demand is one input to the index decision for each page and to which pages the hubs link first.
| Code | Description | Payment limit | Searches / month |
|---|---|---|---|
| A9595 | Piflu f 18 pylarify dx 1 mci | $346.49 (OPPS) | 260 |
| A9607 | Lutetium lu 177 vipivotide | $266.541 (OPPS) | 260 |
| A9575 | Inj gadoterate meglumi 0.1ml | $0.105 | 210 |
| A9585 | Gadobutrol injection | $0.235 | 170 |
| A9596 | Gallium illuccix 1 millicure | $478.52 (OPPS) | 170 |
| A9513 | Lutetium lu 177 dotatat ther | $350.845 (OPPS) | 140 |
| A9573 | Inj, gadopiclenol, 1 ml | $3.222 | 110 |
| A9586 | Florbetapir f18 | $1,825.64 (OPPS) | 110 |
| A9587 | Gallium ga-68 | $49.63 (OPPS) | 110 |
| A9616 | Gallium gozellix 1 millicuri | $1,171.30 (OPPS) | 320 |
Codes in this range
9 of the 53 codes carry a published October 2026 ASP payment limit, 43 show their OPPS rate instead; the remaining codes are priced by contractors or carry a limit of zero in the file. The table lists the 49 codes whose reference pages are indexed; the other 4 follow as a list.
| Code | Descriptor | Unit | Limit | MUE | Col-2 pairs | Articles |
|---|---|---|---|---|---|---|
| A9506 | Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol, one crucible | $328.60 OPPS | 1 | — | — | |
| A9507 | Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries | up to 10 millicuries | $1,730.29 OPPS | 1 | 9 | — |
| A9508 | Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie | 0.5 millicurie | $953.01 OPPS | 2 | 7 | — |
| A9513 | Lutetium lu 177, dotatate, therapeutic, 1 millicurie | 1 mCi | $350.845 OPPS | 200 | — | — |
| A9515 | Choline c-11, diagnostic, per study dose up to 20 millicuries | $2,516.43 OPPS | 1 | — | — | |
| A9517 | Iodine i-131 sodium iodide capsule(s), therapeutic, per millicurie | $24.07 OPPS | 200 | 25 | — | |
| A9521 | Technetium tc-99m exametazime, diagnostic, per study dose, up to 25 millicuries | up to 25 millicuries | $927.71 OPPS | 2 | 24 | — |
| A9532 | Iodine i-125 serum albumin, diagnostic, per 5 microcuries | 5 microcuries | $469.06 OPPS | 10 | 5 | — |
| A9543 | Yttrium y-90 ibritumomab tiuxetan, therapeutic, per treatment dose, up to 40 millicuries | up to 40 millicuries | $74,750.119 OPPS | 1 | 7 | — |
| A9547 | Indium in-111 oxyquinoline, diagnostic, per 0.5 millicurie | 0.5 millicurie | $831.46 OPPS | 2 | 26 | — |
| A9548 | Indium in-111 pentetate, diagnostic, per 0.5 millicurie | 0.5 millicurie | $745.62 OPPS | 2 | 25 | — |
| A9551 | Technetium tc-99m succimer, diagnostic, per study dose, up to 10 millicuries | up to 10 millicuries | $659.93 OPPS | 1 | 17 | — |
| A9553 | Chromium cr-51 sodium chromate, diagnostic, per study dose, up to 250 microcuries | up to 250 microcuries | $1,917.96 OPPS | 1 | — | — |
| A9554 | Iodine i-125 sodium iothalamate, diagnostic, per study dose, up to 10 microcuries | up to 10 microcuries | $649.64 OPPS | 1 | 5 | — |
| A9557 | Technetium tc-99m bicisate, diagnostic, per study dose, up to 25 millicuries | up to 25 millicuries | $775.52 OPPS | 2 | 16 | — |
| A9563 | Sodium phosphate p-32, therapeutic, per millicurie | $278.24 OPPS | 10 | 1 | — | |
| A9569 | Technetium tc-99m exametazime labeled autologous white blood cells, diagnostic, per study dose | $934.13 OPPS | 1 | 15 | — | |
| A9570 | Indium in-111 labeled autologous white blood cells, diagnostic, per study dose | $1,103.19 OPPS | 1 | 22 | — | |
| A9572 | Indium in-111 pentetreotide, diagnostic, per study dose, up to 6 millicuries | up to 6 millicuries | $2,000.94 OPPS | 1 | 25 | — |
| A9573 | Injection, gadopiclenol, 1 ml | 1 ML | $3.222 | 18 | — | — |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0.1 ML | $0.105 | 300 | — | — |
| A9576 | Injection, gadoteridol, (prohance multipack), per ml | 1 ML | $1.345 | 100 | — | — |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 1 ML | $1.804 | 50 | — | — |
| A9578 | Injection, gadobenate dimeglumine (multihance multipack), per ml | 1 ML | $1.697 | 50 | — | — |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 1 ML | $1.435 | 100 | — | — |
| A9581 | Injection, gadoxetate disodium, 1 ml | 1 ML | $14.47 | 20 | — | — |
| A9582 | Iodine i-123 iobenguane, diagnostic, per study dose, up to 15 millicuries | up to 15 millicuries | $2,317.50 OPPS | 1 | 11 | — |
| A9584 | Iodine 1-123 ioflupane, diagnostic, per study dose, up to 5 millicuries | up to 5 millicuries | $1,387.74 OPPS | 1 | 8 | — |
| A9585 | Injection, gadobutrol, 0.1 ml | 0.1 ML | $0.235 | 300 | — | yes |
| A9586 | Florbetapir f18, diagnostic, per study dose, up to 10 millicuries | UP TO 10 mCi | $1,825.64 OPPS | 1 | 1 | — |
| A9587 | Gallium ga-68, dotatate, diagnostic, 0.1 millicurie | 0.1 mCi | $49.63 OPPS | 54 | — | — |
| A9588 | Fluciclovine f-18, diagnostic, 1 millicurie | 1 mCi | $322.27 OPPS | 10 | — | — |
| A9589 | Instillation, hexaminolevulinate hydrochloride, 100 mg | 100 MG | $1,431.00 | 1 | — | — |
| A9591 | Fluoroestradiol f 18, diagnostic, 1 millicurie | 1 millicurie | $460.42 OPPS | 6 | — | — |
| A9592 | Copper cu-64, dotatate, diagnostic, 1 millicurie | 1 mCi | $594.28 OPPS | 4 | — | — |
| A9593 | Gallium ga-68 psma-11, diagnostic, (ucsf), 1 millicurie | 1 mCi | $550.13 OPPS | 7 | — | — |
| A9594 | Gallium ga-68 psma-11, diagnostic, (ucla), 1 millicurie | 1 mCi | $363.50 OPPS | 7 | — | — |
| A9595 | Piflufolastat f 18 (pylarify), diagnostic, 1 millicurie | 1 millicurie | $346.49 OPPS | 10 | — | — |
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | 1 millicurie | $478.52 OPPS | 7 | — | — |
| A9601 | Flortaucipir f 18 injection, diagnostic, 1 millicurie | 1 mCi | $371.00 OPPS | 10 | — | yes |
| A9602 | Fluorodopa f-18, diagnostic, per millicurie | $855.55 OPPS | 5 | — | — | |
| A9604 | Samarium sm-153 lexidronam, therapeutic, per treatment dose, up to 150 millicuries | up to 150 millicuries | $3,159.80 OPPS | 1 | 6 | — |
| A9606 | Radium ra-223 dichloride, therapeutic, per microcurie | 1 microCurie | $180.422 OPPS | 224 | — | yes |
| A9607 | Lutetium lu 177 vipivotide tetraxetan, therapeutic, 1 millicurie | 1 mCi | $266.541 OPPS | 216 | — | — |
| A9608 | Flotufolastat f 18, diagnostic, 1 millicurie | 1 mCi | $715.022 OPPS | 8 | — | — |
| A9611 | Flurpiridaz f 18, diagnostic, 1 millicurie | 1 millicurie | $530.00 OPPS | 13 | — | yes |
| A9615 | Injection, pegulicianine, 1 mg | 1 MG | $37.508 OPPS | 156 | — | — |
| A9697 | Injection, carboxydextran-coated superparamagnetic iron oxide, per study dose | $1,254.00 OPPS | 1 | — | — | |
| A9800 | Gallium ga-68 gozetotide, diagnostic, (locametz), 1 millicurie | 1 mCi | $362.50 OPPS | 7 | — | — |
Show the other 4 codes on this page (pages not yet in search results)
- A9530 Iodine i-131 sodium iodide solution, therapeutic, per millicurie · OPPS $20.77
- A9574 Injection, ferumoxytol, 1 mg · OPPS $0.42
- A9613 Piflufolastat f 18 (pylarify truvu), diagnostic, 1 millicurie · OPPS $652.52
- A9616 Gallium ga-68 gozetotide (gozellix), diagnostic, 1 millicurie · OPPS $1,171.30
How to read this table
The limit is the Medicare Part B payment allowance per billing unit for the quarter shown, not per dose: multiply it by the units that the administered quantity divided by the descriptor unit produces. Codes marked OPPS have no ASP limit and show the hospital outpatient rate per unit instead. The MUE column is the practitioner-setting Medically Unlikely Edit, the maximum units CMS expects on one date of service; facility and DME limits can differ and appear on each code page. Column-2 pairs counts the active NCCI procedure-to-procedure edits in which the code is the bundled component, and Articles marks codes that at least one Medicare Administrative Contractor lists in a current Billing and Coding Article with covered diagnosis codes. Codes without a published limit are contractor-priced or carry a zero limit in the CMS file.
In QuickIntell research
- October 2026 ASP movers report: The 75 drug codes whose payment limit moved 20% or more since July 2026, and the 37 priced for the first time.
- October 2026 HCPCS update report: The codes CMS added and discontinued in the latest quarterly release, with replacements; the 2026 roll-up covers every quarter.
- 2026 Q4 most-bundled codes report: The codes NCCI bundles most often as column 2, and the 12 Part B drug codes it bundles at all.
- J codes by drug name: Find the J code, or every code, for a drug by generic or brand name.
For teams evaluating QuickIntell software
Evaluate software for HCPCS coding workflows
Evaluating a recurring coding workflow? Review QuickCode for qualified coder review, documentation clarification and the billing handoff. Use your unit, modifier and edit questions to confirm the supported scope; a published CMS table does not establish an automated claim check.
Optional software evaluation, not payer support or help with an individual claim. For coverage or payment decisions, use the official sources on this page. Do not include patient information in a demo booking or inquiry.
Frequently asked questions
How many codes are in radiopharmaceuticals, contrast and other drugs (a codes)?
53 Part B drug codes in this range: 9 carry an ASP payment limit in the October 2026 file and 43 are paid separately under OPPS without an ASP limit; 49 have enough joined CMS data (MUE, NCCI, OPPS, ASC or coverage) to be published as full reference pages.
Which payers use these payment limits?
Medicare Part B contractors apply the ASP limits directly. Medicaid programs and commercial payers publish their own fee schedules, which often reference ASP but at different percentages.
Why do some codes show no MUE?
CMS withholds some MUE values as confidential and applies them without publication; others have no unit limit. A code with no published MUE can still deny for units when the quantity is implausible for the dose.
Sources
Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-11-16. Verify against the primary file before billing or contracting decisions. The reference methodology explains how each figure is computed from these files.
- Medicare Part B Drug Payment Limit File, October 2026Version October 2026 · effective 2026-10-01 · file section 508 version of October 2026 Medicare Part B Payment Limit File 091626.csvSHA-256 508fba376a29e099…
- NCCI MUE table, practitioner services, effective 2026-10-01Version 2026 Q4 · effective 2026-10-01 · file MCR_MUE_PractitionerServices_Eff_10-01-2026.csvSHA-256 ef038efaf902b7bd…
- NCCI PTP edits, practitioner, v323r0 (four files)Version v323r0 (2026 Q4) · effective 2026-10-01 · file ccipra-v323r0-f1.TXTSHA-256 7793c0b6686c1e22…
- OPPS Addendum B, October 2026Version October 2026 · effective 2026-10-01 · file 508-compliant-version-2026_October_Web_Addendum_B.09.28.26.csvSHA-256 6ad7393a318bf1b9…
Disclaimer
Operational reference compiled from CMS publications. Payment limits are Medicare national amounts; other payers differ. CPT codes appear as numbers only. Not legal, clinical or billing advice.
Found a figure that does not match the CMS file? Report a data correction with the CMS file and the value you expected; the request reaches the editorial team through the contact form.